LAVA Therapeutics NV (LVTX) — Cash Flow Reinvestment Rate
LAVA Therapeutics NV (LVTX) has a Cash Flow Reinvestment Rate of 0.12x as of December 2022, reinvesting $4.40 Million (capex $265.00K plus investments $-4.14 Million) from operating cash flow of $35.73 Million. Explore capital reinvestment ratio of LAVA Therapeutics NV to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
LAVA Therapeutics NV Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for LAVA Therapeutics NV across 1 annual periods. Also explore how large is LAVA Therapeutics NV's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for LAVA Therapeutics NV (2022–2022)
Year-by-year capital reinvestment analysis for LAVA Therapeutics NV. For live market cap and broader valuation context, see how much is LAVA Therapeutics NV worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 2.46x | $9.93 Million | $4.04 Million | $587.00K | — |